Skip to main content

Advertise with us

  • Post jobs
  • Search for candidates
  • Recruiting Physicians Today

This job has expired

ADC Biology Group Leader

Employer
Innovent Biologics
Location
Maryland
Posted Date
Oct 24, 2021

View more

Specialty
Research
Position Type
Permanent

Job Details

ADC Biology Group Leader

Job Summary:

Innovent Biologics is seeking an ADC Biology group leader for their Maryland site, U.S. The group leader will lead a team of scientists in developing cell-based in vitro assays, high throughput screens, evaluate antibody/ADC binding, and evaluate antibody/ADC internalization and intracellular trafficking.

Job Responsibilities:

  • Develop high throughput in-vitro cytotoxicity and apoptosis assays to evaluate ADCs and ADC payloads.
  • Use multi-color FACS analysis to evaluate antibody/ADC binding, antibody/ADC internalization and intracellular trafficking.
  • Develop ELISA assays.
  • Develop stable recombinant cell lines expressing luciferase, GFP, and other proteins.
  • Develop cell lines using CRISPR.
  • Work collaboratively with colleagues and collaborators.
  • Mentor and support the career development of direct reports.

Requirements:

  • PhD with 1-3 years of experience working in a biotechnology/pharmaceutical company environment.
  • Able to work on multiple projects simultaneously and prioritize the tasks to meet timelines.
  • Must be able to generate reproducible and high-quality data to support IND submissions and reports.
  • Must have experience culturing human tumor cell lines, primary cells, and establishing recombinant cell lines.
  • Must be possess excellent communication skills and be able to present complex concepts to an audience of varying expertise.
  • Must have good leadership and mentoring skills. 
  • Must have meticulous record keeping.

Please apply with brief cover letter and CV.

Job Type: Full-time

Benefits:

  • 401(K)
  • Dental insurance
  • Health insurance
  • Paid time off

Innovent Biologics is committed to equal treatment and opportunity in all aspects of recruitment, selection, and employment without regard to gender, race, religion, national origin, ethnicity, disability, gender identity/expression, sexual orientation, veteran or military status, or any other category protected under the law. Innovent Biologics is an Equal Opportunity Employer; committed to a community of inclusion, and an environment free from discrimination, harassment, and retaliation.

Contacts
Contact People: Lucy Zhang
Tel: 1-301 578 2600
E-mail: Lucy.zhang@innoventbio.com

Company

Excellent Employment Opportunities Available at Innovent Biologics

Established in 2011, Innovent is committed to developing, manufacturing, and commercializing high quality innovative medicines for the treatment of major diseases such as cancer. On 31 October, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK. Since its inception, Innovent has developed a fully-integrated multi-functional platform which includes R&D, CMC (Chemistry, Manufacturing, and Controls), clinical development and commercialization capabilities. Leveraging the platform, the company has built a robust pipeline of 23 valuable assets in the fields of cancer, metabolic, autoimmune diseases, and other major therapeutic areas, with 4 products, TYVYT® (sintilimab injection), BYVASDA® (bevacizumab injection), SULINNO® (adalimumab injection), HALPRYZA® (rituximab injection) officially approved for marketing in China, 5 assets in Phase III or pivotal clinical trials, and additional 14 molecules in to clinical trials. TYVYT® was included in the National Reimbursement Drug List (NRDL) in 2019 as the only PD-1 in that year and was also the first PD-1 inhibitor included in NRDL historically. Innovent has built a biopharmaceutical production facility that operates under global standards. The design and operation of the clinical and commercial facilities are in compliance with the cGMP standards of NMPA, FDA, and EMA. The existing production lines have already passed GMP audits by an international pharmaceutical company. Innovent has built an international team of advanced talents in high-end biological drug development and commercialization, including many overseas experts. The company has also entered into strategic cooperation with Eli Lilly, Adimab, Incyte, Hanmi and other international pharmaceutical companies.

Innovent is genuinely recruiting the talents domestically and internationally. You are more than welcome to join us, where the sky is the limit.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert